Munich, Georgia

Lars Hillringhaus

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Location History:

  • Königsdorf-Schönrain, DE (2021)
  • Konigsdorf-Schonrain, DE (2023)

Company Filing History:


Years Active: 2021-2023

where 'Filed Patents' based on already Granted Patents

2 patents (USPTO):

Title: Lars Hillringhaus: Innovator in Nucleic Acid Sequencing

Introduction

Lars Hillringhaus is a notable inventor based in Munich, Germany. He has made significant contributions to the field of nucleic acid sequencing, particularly through his innovative work with polypeptide-tagged nucleotides. With a total of 2 patents, Hillringhaus is recognized for his advancements in nanopore detection technologies.

Latest Patents

Lars Hillringhaus's latest patents include compositions and methods based on polypeptide-tagged nucleotides. These inventions focus on the use of such nucleotides in nucleic acid sequencing by nanopore detection. The present disclosures highlight the potential applications of polypeptide-tagged nucleotides in nanopore devices and methods, showcasing his commitment to advancing scientific research.

Career Highlights

Throughout his career, Lars has worked with prominent companies in the biotechnology sector. He has been associated with Roche Sequencing Solutions, Inc. and Roche Molecular Systems, Inc. His experience in these organizations has allowed him to develop and refine his innovative ideas in the field of molecular biology.

Collaborations

Lars has collaborated with esteemed colleagues such as Frank Bergmann and Christoph Seidel. These partnerships have contributed to the successful development of his patents and have fostered a collaborative environment for innovation.

Conclusion

Lars Hillringhaus is a distinguished inventor whose work in nucleic acid sequencing has the potential to revolutionize the field. His contributions through innovative patents and collaborations with industry leaders underscore his importance in advancing biotechnology.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…